Article
Progressive cutaneous sarcoidosis responding to anti-tumor necrosis factor-alpha therapy.
Journal of the American Academy of Dermatology - 1 Feb 2003
Mallbris Lotus, Ljungberg Anders, Hedblad Mari-Anne, Larsson Per, Ståhle-Bäckdahl Mona
Abstract excerpt
We describe a patient with widespread and progressive cutaneous sarcoidosis who was successfully treated with anti-tumor necrosis factor-alpha monoclonal antibody, infliximab, suggesting that inhibition of tumor necrosis factor-alpha may be useful as targeted treatment in cutaneous sarcoidosis.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
